IRIS
MARAMPON, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.129
EU - Europa 723
AS - Asia 195
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 2.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.125
IE - Irlanda 298
CN - Cina 130
DE - Germania 123
IT - Italia 81
SE - Svezia 79
UA - Ucraina 45
GB - Regno Unito 33
TR - Turchia 31
SG - Singapore 24
BE - Belgio 17
CZ - Repubblica Ceca 15
FR - Francia 15
VN - Vietnam 7
FI - Finlandia 6
AU - Australia 3
CA - Canada 3
EU - Europa 3
NL - Olanda 2
PT - Portogallo 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CH - Svizzera 1
ES - Italia 1
IL - Israele 1
IN - India 1
JP - Giappone 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
Totale 2.054
Salva come PNG Salva come JPEG
Città #
Chandler 306
Dublin 294
Jacksonville 183
Ann Arbor 63
Ashburn 57
New York 52
Lawrence 34
Princeton 34
Wilmington 34
L'aquila 33
Bremen 32
Munich 32
Beijing 27
Nanjing 27
Izmir 24
Singapore 20
Boardman 18
Brussels 17
Woodbridge 16
San Mateo 15
Brno 14
Falls Church 12
Grafing 12
Des Moines 10
Seattle 9
Shenyang 9
Washington 9
Cambridge 8
L’Aquila 8
Mountain View 8
Dearborn 7
Milan 7
Changsha 6
Dong Ket 6
Hebei 6
Nanchang 6
Norwalk 6
Kunming 5
Los Angeles 5
Shanghai 5
Tianjin 5
Berlin 4
Hanover 4
Napoli 4
Zhengzhou 4
Dallas 3
Guangzhou 3
Houston 3
Jinan 3
Rome 3
Tappahannock 3
Verona 3
Bolton 2
Braga 2
Fremont 2
Jiaxing 2
Lanzhou 2
Menlo Park 2
Ningbo 2
Piombino Dese 2
Redwood City 2
Saint Paul 2
Toronto 2
Vittuone 2
Adliswil 1
Amsterdam 1
Beauharnois 1
Bellante 1
Canberra 1
Carlentini 1
Cedar Knolls 1
Cormeilles-en-Parisis 1
Detroit 1
Edinburgh 1
Fairfield 1
Frankfurt am Main 1
Gainesville 1
Gold Hill 1
Groningen 1
Hanoi 1
Irkutsk 1
Lodi 1
Logan 1
Madrid 1
Moscow 1
Nanning 1
Nuremberg 1
Panama City 1
Pune 1
San Diego 1
Sydney 1
Taizhou 1
Tel Aviv 1
Teramo 1
Tokyo 1
Vienna 1
Villeneuve 1
Warsaw 1
Totale 1.576
Salva come PNG Salva come JPEG
Nome #
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 102
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 94
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 94
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 89
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3receptors 83
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study 76
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 76
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: A retrospective study by propensity analysis 74
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis 74
Neurotoxic and Neuroprotective Role of Exosomes in Parkinson's Disease 70
Dichlorodiphenyltrichloroethane, an old pesticide with a new mechanism of toxicity 69
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 66
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 65
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 65
The First Negative Allosteric Modulator for Dopamine D2and D3Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs 63
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models 62
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models 57
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 56
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 56
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 55
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 53
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 50
A New Threat to Dopamine Neurons: The Downside of Artificial Light 50
Parkinson's disease and light: The bright and the Dark sides 49
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 48
Allosteric modulators of g protein-coupled dopamine and serotonin receptors: A new class of atypical antipsychotics 48
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma 44
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 43
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis 43
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma 41
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 39
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 38
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 33
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 33
Interaction of the preferential D3 agonist (+)PHNO with dopamine D3-D2 receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imaging 23
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications 21
The C-terminus of the prototypical M2 muscarinic receptor localizes to the mitochondria and regulates cell respiration under stress conditions 14
Totale 2.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.363
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020187 0 1 19 4 3 39 40 4 30 17 5 25
2020/2021267 5 27 11 27 27 9 36 2 43 12 52 16
2021/2022249 11 2 38 12 12 21 9 7 36 20 15 66
2022/2023834 49 69 12 124 61 85 0 45 352 7 20 10
2023/2024257 20 12 16 9 19 94 12 12 0 6 21 36
2024/202548 32 16 0 0 0 0 0 0 0 0 0 0
Totale 2.116